Skip to main content Skip to main navigation menu Skip to site footer

Depresi yang diinduksi insulin dan nyeri kronis pada pasien neuropati diabetik dengan paraparesis tipe lower motor neuron: sebuah laporan kasus

  • Petrus Agustinus Seda Sega ,
  • Ida Ayu Sri Indrayani ,
  • Anak Ayu Sri Wahyuni ,


Abstract

Background: Indonesia ranks 4th in terms of the number of people with diabetes mellitus in the world, and chronic complications in DM include disorders of the nerves (neuropathy). Paraparesis causes disturbances in mobility and disturbances to the person, namely the perception of his disability which can lead to reactions of disappointment, low self-esteem and ends in despair and depression. This case report aims to describe insulin-induced depression and chronic pain in diabetic neuropathy patient with lower motor neuron paraparesis.

Case Presentation: A 36-year-old Balinese woman could not walk, she had been complaining of sadness for a long time, since she was told she had diabetes, thus limiting her daily activities. The patient has a history of diabetic disease since childhood and was definitely diagnosed at the age of 15 around 18 years ago, and started a history of back pain since December 2021 and worsened with cramps and weakness in both legs since January 2022. Vital signs were good, on waist is attached plate metal as high as vertebrae L3–L4, extremities: edema +/- warm +/+, cruris dextra: edema (+), clinical neurology: lower motor neuron type paraparesis, motor weakness, atrophy of musculus gastrocnemius dextra et sinistra and musculus tibialis dextra et sinistra paresthesia of the glove and stocking type. Psychiatric status: reasonable appearance of consciousness: clear, affective. Mood affect: sad/depressive/ appropriate. Thought process: logical realist/coherent/preoccupation with back pain and weak legs. Mixed-type insomnia exists; history of raptus and hypobulia is present. Impulse control: poor.

Conclusion: Patients with diabetes on insulin treatment were associated with the prevalence of depressive syndromes.

 

Latar belakang: Indonesia menempati urutan ke-4 terbesar dalam jumlah penderita diabetes melitus di dunia, dan komplikasi kronis pada diabetes antara lain kelainan pada saraf (neuropati). Paraparese menyebabkan gangguan dalam mobilitas serta gangguan terhadap pribadinya yaitu persepsi kecacatannya yang dapat menimbulkan reaksi kecewa, rendah diri dan berakhir pada keadaan putus asa dan depresi. Laporan kasus ini bertujuan mendeskripsikan depresi yang diinduksi insulin dan nyeri kronis pada pasien neuropati diabetik dengan paraparesis tipe lower motor neuron.

Presentasi Kasus:  Perempuan 36 tahun suku Bali, tidak bisa berjalan, keluhan sedih sudah lama, semenjak dikatakan mempunyai penyakit diabetes, sehingga membatasi aktivitasnya sehari hari. Pasien memiliki riwayat penyakit diabetes dari kecil dan terdiagnosis pasti pada umur 15 tahun sekitar 18 tahun yang lalu, dan mulai riwayat nyeri punggung sejak bulan desember 2021 dan memberat dengan kram dan lemah pada kedua kaki sejak Januari 2022.  Tanda vital baik, pada pinggang terpasang: plat logam setinggi vertebra L3–L4, ekstremitas: edema +/- hangat +/+, kruris dekstra: edema (+). Klinis neurologis: paraparesis tipe lower motor neuron, kelemahan motorik, atrofi musculus gastrocnemius dekstra et sinistra dan musculus tibialis dekstra et sinistra, parestesia tipe gloves and stocking. Status psikiatri: penampilan wajar kesadaran: jernih. Mood afek: sedih/depresif/appropriate. Proses pikir: logis realis/koheren/preokupasi nyeri punggung dan lemah kaki. Insomnia tipe campuran ada; raptus ada riwayat dan hipobulia ada. Pengendalian impuls: kurang baik.

Simpulan: Diabetes pada pengobatan insulin dikaitkan dengan prevalensi sindrom depresi, menunjukkan hubungan yang permanen dan signifikan.

Keywords: depresi lower motor neuron neuropati diabetik paraparese

References

  1. Bai X, Liu Z, Li Z, Yan D. The association between insulin therapy and depression in patients with type 2 diabetes mellitus: a meta-analysis. BMJ Open. 2018;8(11):e020062.
  2. Woo YS, Lim HK, Wang SM, Bahk WM. Clinical evidence of antidepressant effects of insulin and anti-hyperglycemic agents and implications for the pathophysiology of depression-a literature review. Int J Mol Sci. 2020;21(18):6969.
  3. van der Feltz-Cornelis C, Allen SF, Holt RIG, Roberts R, Nouwen A, Sartorius N. Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: Systematic review and meta-analysis. Brain Behav. 2021;11(2):e01981.
  4. Fitrikasari A, Wardani ND, Sumekar TA, Saktini F, Asikin HG, Sulchan M. The role of psychosocial stressors, carbohydrate and protein intake on serum serotonin and cortisol levels in patients with depression: a preliminary evaluation. Bali Medical Journal. 2021;10(1):137-141.
  5. McIntyre RS, Alda M, Baldessarini RJ, et al. The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry. 2022;21(3):364-387.
  6. Fanelli G, Franke B, De Witte W, et al. Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders. Transl Psychiatry. 2022;12(1):59.
  7. Oraki M, Zarrati N, Zarrati I. Comparison of life expectancy, quality of life, irrational health beliefs, health locus of control and hospital depression in patients undergoing hemodialysis and heart transplant in Shahid-Rajaee hospital. Bali Medical Journal. 2018;7(1): 177-181.
  8. Wang H, He Y, Sun Z, et al. Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J Neuroinflammation. 2022;19(1):132.
  9. Wijaya IPS, Wihastuti TA, Wiyasa IWA, Effendi MC. The difference of depression level in pregnant women based on the acceptance of pregnancy during the COVID-19 pandemic: a study on pregnant women in Bontang, East Kalimantan. Bali Medical Journal. 2023;12(2):1181-1186.
  10. Sharma AN, da Costa e Silva BF, Soares JC, Carvalho AF, Quevedo J. Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies. J Affect Disord. 2016;197:9-20.
  11. Appleton KM, Voyias PD, Sallis HM, et al. Omega-3 fatty acids for depression in adults. Cochrane Database Syst Rev. 2021;11(11):CD004692.
  12. Lamers F, Bot M, Jansen R, et al. Serum proteomic profiles of depressive subtypes. Transl Psychiatry. 2016;6(7):e851.
  13. Zou XH, Sun LH, Yang W, Li BJ, Cui RJ. Potential role of insulin on the pathogenesis of depression. Cell Prolif. 2020;53(5):e12806.
  14. Wedari NLPH, Budayanti NNS, Sukrama IDM, Mayura IPB. Implementation of antinuclear antibodies in autoimmune diagnostic tests: a literature review from immunological aspects. Journal of Clinical Microbiology and Infectious Diseases. 2022;2(2):27-30.
  15. Borbély É, Simon M, Fuchs E, Wiborg O, Czéh B, Helyes Z. Novel drug developmental strategies for treatment-resistant depression. Br J Pharmacol. 2022;179(6):1146-1186.

How to Cite

Sega, P. A. S., Indrayani, I. A. S. ., & Wahyuni, A. A. S. . (2023). Depresi yang diinduksi insulin dan nyeri kronis pada pasien neuropati diabetik dengan paraparesis tipe lower motor neuron: sebuah laporan kasus. Intisari Sains Medis, 14(2), 540–543. https://doi.org/10.15562/ism.v14i2.1758
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
0

Share

Search Panel

Petrus Agustinus Seda Sega
Google Scholar
Pubmed
ISM Journal

Ida Ayu Sri Indrayani
Google Scholar
Pubmed
ISM Journal

Anak Ayu Sri Wahyuni
Google Scholar
Pubmed
ISM Journal